Since the completion of the first human genome sequencing project in 2003, the potential for incorporating genomics into clinical practice in the pursuit of precision medicine has garnered a great amount of attention and interest. Existing literature presents a dichotomous view of the future of medicine: either precision medicine will replace race-based medicine or race-based medicine will persist despite developments in genetic research and genomic medicine. Drawing on interview data with 46 physicians and scientists in the USA, Canada, and Singapore who are conducting research or practicing precision medicine in the context of cancer treatment and prevention, this article attempts to contribute to the existing debate by proposing a ‘relative resources’ perspective to explain which approach will dominate in a particular healthcare setting. The author elaborates on the ‘heterogeneity of resources’ and suggests that the extent to which precision medicine will be personalized or racialized/ethnicized in the clinic will most likely be a function of the relative availability of resources – including but not limited to financial, human and computer informatics, and legal and infrastructural resources – at individual and collective levels in healthcare contexts.

中文翻译：

---

在个性化和种族化精准医疗之间：相对资源视角

自 2003 年第一个人类基因组测序项目完成以来，将基因组学纳入临床实践以追求精准医疗的潜力引起了广泛的关注和兴趣。现有文献对医学的未来提出了二分法：要么精准医学将取代基于种族的医学，要么基于种族的医学将在遗传研究和基因组医学取得发展的情况下持续存在。本文利用对美国、加拿大和新加坡的 46 名在癌症治疗和预防背景下进行精准医学研究或实践的医生和科学家的访谈数据，试图通过提出“相关资源”来为现有的辩论做出贡献观点来解释哪种方法将在特定的医疗保健环境中占主导地位。